PTHS
Pelthos Therapeutics Inc.
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Pelthos Therapeutics (PTHS) Stock: Buy, Sell, or Hold?
$8.03
-1.36 (-14.48%)
▼
5d:
-13.66%
30d:
-60.35%
90d:
-70.8%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$10.98 – $20.65
Position: OVERSOLD
Forward P/E & Valuation
-1.5x
Next 12M consensus est.
Wall Street Target
$49.57
+517.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.79 / $20.50
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: PTHS is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When PTHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PTHS is currently trading at $8.03, which is considered oversold relative to its 30-day fair value range of $10.98 to $20.65.
Technical Outlook: Technically, PTHS is in a strong downtrend. Immediate support is located at $7.79, while resistance sits at $20.50. Short-term momentum is weak, with the stock down 14.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.57 (+517.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PTHS is in a strong downtrend. Immediate support is located at $7.79, while resistance sits at $20.50. Short-term momentum is weak, with the stock down 14.5% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.57 (+517.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.98 -
$20.65
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$10.98 -
$20.65
Current vs Trading Range
OVERSOLD
Support Level
$7.79
Resistance Level
$20.50
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-14.5%)
- BULLISH: Trading 517.3% below Wall St target ($49.57)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.50
Wall Street Target
$49.57
(+517.3%)
Profit Margin
-199.5%
Share PTHS Analysis
Share this live PTHS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PTHS)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 2, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expresses patience and optimism regarding $PTHS stock despite a rough few months.
Key Retail Themes:
Patience
Optimism
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 51 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 36 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PTHS Research Pages
